Tobira Pharmaceuticals

Tobira pulls off a $40M Wall Street end-around with sights set on NASH
Fierce Biotech
Tue, 05/5/15 - 09:41 am
Tobira Pharmaceuticals
NASH
Regado Biosciences
Biotech Weekly: The Failed Biotech Life Cycle And The Regado-Tobira Merger
Seeking Alpha
Tue, 01/20/15 - 09:28 am
Regado Biosciences
M&A
Tobira Pharmaceuticals